Kurz gefasst
Übersichtsarbeit in der Zeitschrift PET Clinics, 2024. Verfasst von Lisa Bodei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Radiology, W…. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Radiopharmaceuticals, Octreotide, Radioisotopes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Ipsen Biopharmaceuticals, Memorial Sloan-Kettering Cancer Center, Instituto Tecnológico Metropolitano.
Abstract (Originalsprache)
Peptide receptor radionuclide therapy (PRRT) consists of administrating a radiolabeled octreotide derivative that targets somatostatin receptors present on the cell membrane of neuroendocrine tumor cells. Although PRRT was initially performed with 90Y-peptides, currently 177Lu-peptides represent the predominant form of treatment. PRRT results in significant tumor and symptomatic control in patients. Like with other available systemic therapies, responses are relatively short-lived. Several new peptides and strategies to improve the efficacy and tolerability of PRRT have been proposed. A critical step is individualizing treatments based on specific dosimetric estimates for the tumor and normal organs, and determining tissue radiosensitivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Radiology, Weill Cornell Medical College of Cornell University, New York, NY, USA.…
- Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Radiology, Weill Cornell Medical College of Cornell University, New York, NY, USA.
- Department of Radiology, Weill Cornell Medical College of Cornell University, New York, NY, USA.
- Division of Nuclear Medicine, Department of Radiology, University of Stanford, Stanford, CA, USA.
Förderung
- Ipsen Biopharmaceuticals
- Memorial Sloan-Kettering Cancer Center
- Instituto Tecnológico Metropolitano
Zitieren
APA
Bodei, L., Jayaprakasam, V. S., Ying Wong, B. Z., & Aparici, C. M. (2024). Neuroendocrine Tumors. PET Clinics. https://doi.org/10.1016/j.cpet.2024.06.003
Vancouver
Bodei L, Jayaprakasam VS, Ying Wong BZ, Aparici CM. Neuroendocrine Tumors. PET Clinics. 2024. doi:10.1016/j.cpet.2024.06.003
BibTeX
@article{Bodei2024,
author = {Bodei, Lisa and Jayaprakasam, Vetri Sudar and Ying Wong, Bernadette Zhi and Aparici, Carina Mari},
title = {Neuroendocrine Tumors},
journal = {PET Clinics},
year = {2024},
doi = {10.1016/j.cpet.2024.06.003}
}
EUVIMED